Preparation and Evaluation of Bupivacaine Microspheres by a Solvent Evaporation Method (II)

용매증발법에 의한 부피바카인 마이크로스피어의 제조 및 평가 (II)

  • Published : 2001.12.01

Abstract

Various bupivacaine-loaded microspheres were prepared using poly(d,1-lactide) (PLA) and poly(d,1-lactic-co-glycolide) (PLGA) by a solvent evaporation method for the sustained release of drug. The effects of process conditions such as drug loading, polymer type and solvent type on the characteristics of microspheres were investigated. The prepared microspheres were characterized for their drug loading, size distribution, surface morphology and release kinetics. Drug loading efficiency and yield of PLGA micro- spheres were higher than those of PLA microspheres. The prepared microspheres had an average particle size below 5${\mu}{\textrm}{m}$. The particle size range of microspheres was 1.65~2.24${\mu}{\textrm}{m}$. As a result of SEM, the particle size of PLA microspheres was smaller than that of PLGA microspheres. In morphology studies, microspheres showed a spherical shape and smooth surface in all process conditions. In thermal analysis, bupivacaine-loaded microspheres showed no peaks originating from bupivacaine. This suggested that bupivacaine base was molecular-dispersed in the polymer matrix of microspheres. The release pattern of the drug from microspheres was evaluated for 96 hours. The initial burst release of bupivacaine base decreased with increasing the molecular weight of PLGA, and the drug from microspheres released slowly. In conclusion, bupivacaine-loaded microspheres were successfully prepared from poly(d,1-lactide) and poly (d,1- lactic-co-glycolide) polymers with different molecular weights allowing control of the release rate.

Keywords

References

  1. Particulate Sci. Technol. v.5 no.53 Particles as drug delivery systems Wheatley, M.;Langer, R.
  2. Int. J. Pharm. v.84 no.151 Solvent evaporation, solvent extraction and spray drying for polylactide microsphere preparation Pavanetto, F.;Conti, B.;Genta, I.;Giunchedi, P.
  3. Proceedings 33rd Simposio AFI Preparation and evaluation of tolmetin loaded poly-D, L-lactide microspheres Conti, B.;Puglisi, G.;Ventura, C.A.;Giunchedi, P.;Conte, U.
  4. J. Control. Rel. v.6 no.167 Prolonged delivery of peptides by microcapsules Maulding, H. V.
  5. Polym. Eng. Sci. v.30 no.915 Microspheres and microapsules, a survey of manufacturing techniques: part Ⅲ: solvent evaporation Arshady, R.
  6. Polymer J. v.19 no.5 Microspheres of biodegradable block copolymer for long-acting controlled delivery of contraceptives Song, C. X.;Sun, H. F.;Feng, X. D.
  7. Neuroradiology v.32 no.485 (d,l)Polylactide microspheres as embolic agent, A preliminary study Flandroy, P.;Grandfils, C.;Collignon, J.;Thibaut, A.;Nihant, N.;Barbette, S.;Jeroem, R.;Teyssie, Ph.
  8. J. Biomed. Mat. Res. v.26 no.467 Preparation of poly(d,l)lactide microspheres and their clinical applications as a convenient embolic material Grandfils, C.;Flandroy, P.;Nihant, N.;Barbette, S.;Jeroeme, R.;Teyssie, Ph.
  9. J. Control. Rel. v.16 no.177 In vivo peptide release from poly(DL-lactic acid-co-glycolic acid) copolymer 50/50 microspheres Ruiz, J. M.;Benoit, J. P.
  10. Polymer v.35 no.777 Microencapsulation of poly(lactide-co-glycolide), Ⅰ. Physico-chemical characteristics of the phase separation process Stassen, S.;Nihant, N.;Martin, V.;Grandfils, C.;Jeroeme, R.;Teyssie, Ph.
  11. Polym. Int. v.32 no.171 Microencapsulation by coacervation of poly(lactide-co-glycolide), Ⅱ. Encapsulation of a dispersed aqueous phase Nihant, N.;Stassen, S.;Grandfils, C.;Jeroeme, R.;Teyssie, Ph.
  12. J. Pharm. Sci. v.79 no.919 Lactic acid oilgomer microspheres containing hydrophilic drugs Wada, R.;Hyon, S. H.;Ikada, Y.
  13. J. Microencapsulation v.6 no.473 Microencapsulation using poly(L-lactic acid) : Ⅰ.Microcapsule properties affected by the preparative technique Jalil, R.;Nixon, J. R.
  14. Fertil. Steril. v.31 no.5 A new long action injectable microcapsules system for the administration of progesterone Beck, L. R.;Cowsar, D. R.;Lewis, D. H.;Cosgrave, R. J.;Riddle, C. T.;Lowry, S. L.;Epperly, T. E.
  15. Pharm. Res. v.5 no.21 Porous biodegradable microspheres for controlled drug delivery:Ⅰ.Assessment of process conditions and solvent removal techniques Sato, T.;Kanke, M.;Schroeder, H. G.;DeLuca, P. P.
  16. Clin. Pharmacokinet v.16 no.283 Clinical Pharmacokinetics of epidural and spinal anaesthesia Burm, A. G. C.
  17. Ann. Thorac. Surg. v.53 no.449 Intrapleural bupivacaine in the control of postthoracotomy pain Mann, L. J.;Young, G. R.;Williams, J. K.;Dent, O. W.;McCaughan, B. C.
  18. Eur. J. Clin. Pharmacol. v.42 no.223 Serum concentrations of local anaesthetics following intraperitoneal administration drug laparoscopy Narchi, P.;Benhamou, D.;Bouaziz, H.;Fernandez, H.;Mazoit, J. M.
  19. Br. J. Anaesth. v.58 no.701 Pharmacology of local anaesthetic agents Covino, B. G.
  20. Nippon Seikeigeka Gakkai Zasshi. v.67 no.473 Effect of phenol block on peripheral nerve : Morphometric and histochemical study in rats Tsukazak, T.;Ito, N.;Maeda, H.;Iwasaki, K.
  21. Masui. v.42 no.606 Treatment of hyperhydrosis with caudal epidural alcohol block in a patient with cervical cord injury Yamauchi, Y.;Kojoh, H.;Nagaro, T.;Miyazaki, H.;Kimura, S.;Aria, T.
  22. Clin. J. Pain. v.12 no.311 Neurosurgery for trigeminal neuralgia : Comparison of alcohol block, neurectomy and radiofrequency coagulation Oturai, A. B.;Tensen, K.;Eriksen, J.;Madsen, F.
  23. Masui. v.44 no.1537 Efficacy of epidural neurolysis Hango, T.;Tsunoda, K.;Egami, Y.;Ohi, Y.;Sakamot, A.;Inoue, T.
  24. Eur. J. Cardiothorac. Surg. v.7 no.561 Intercostal nerve block, interpleural analgesia, thotacic epidural block or systemic opioid application for pain relif after thoracotomy Zapatero, J.
  25. Anesthesiology v.68 no.665 New routes of administration and new delivery systems of anesthetics Stanley, T. H.
  26. Int. J. Pharm. v.84 no.33 Slow-release effect of pH-adjusted bupivacaine: invitro demonstration Bonhomme, L.;Benhamou, D.;Beugre, T.
  27. Anesthesiology v.74 no.105 Spinal anesthesia: Significant prolongation of the pharmacologic effect of tetracaine with lipid solution of the agent Langerman, L.;Golomb, E.;Benita, S.
  28. Anesthesiology v.75 no.950 Long-lasting epidural sensory blockade by n-butyl-p-aminobenzoate in the terminally ill intractable cancer pain patient Korsten, H. H. M.;Ackerman, E. W.;Grouls, R. J. E.;Van Zundert, A. A. J.;Boon, W. N.;Bal, F.;Crommelin, M. A.;Ribot, J. G.;Hoefsloot, F.;Slooff, J. L.
  29. Int. J. Pharm. v.62 no.249 Controlled release of local anesthetic agents from liquid-solid emulsion gels Mhando, J.R.;Li Wan Po, A.
  30. Int. J. Pharm. v.81 no.103 Release of benzocaine, procaine, 2-aminothiazole and 4-amino-4H-1,2,4-triazole from polymer carriers Kolli, M.;Montheard, J. P.;Vergnaud, J. M.
  31. Anesthesiology v.75 no.A765 Prolonged sciatic nerve blockade using sustained release of bupivacaine from a biodegradable polymer matrix Masters, D.B.;Berde, C. B.;Dutta, S.;Langer, R.
  32. Anesth. Analg. v.75 no.900 Prolongation of epidural anesthesia using a lipid drug carrier with procaine, lidocaine and tetracaine Langerman, L.;Grant, G. J.;Zakowski, M.;Golomb, E.;Ramanathan, S.;Turndorf, H.
  33. Anesth. Analg. v.74 no.827 Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine Mashimo, T.;Uchida, I.;Pak, M.;Shibata, A.;Nishimura, S.;Inagaki, Y.;Yoshida, I.
  34. Chem. Pharm. Bull. v.30 no.3719 Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine Wakiyama, N.;Juni, K.;Nakano, M.
  35. Yakhak Hoeji v.44 no.511 Preparation and evaluation of bupivacaine microspheres by a solvent evaporation method Kwak, S. H.;Hwang, S. J.;Lee, B. C.
  36. Int. J. Pharm. v.43 no.179 Solvent selection in the preparation of poly(DL-lactide) microspheres prepared by the solvent evaporation method Bodmeier, R.;McGinity, J. W.